TACR1 and acute lymphoblastic leukemia: Nevertheless, the role of NK-1R in the pathogenesis of human hematological malignancy has not been systematically characterized, although one study showed inhibition of cell proliferation by NK-1R antagonists in acute lymphoblastic leukemia (28).